1. Peri-operative management of anticoagulation and anti-platelet therapy. D Keeling, RC Tait, HG Watson. B J Haematol 2016, 175: 602-613.
  2. Guideline on aspects of cancer-related venous thrombosis. H G Watson, DM Keeling, M Laffan et al. B J Haematol 2015, 170: 640-648.
  3. Measurement of non-Coumarin anticoagulants and their effects on test of haemostasis: Guidance from the British Committee for Standards in Haematology. S Kitchen, E Gray, I Mackie et al. Br J Haematol. 2014, 166: 830-841.
  4. Guideline on the management of bleeding in patients on antithrombotic agents. M Markis, J J van Veen, CR Tait et al. Br J Haematol 2013, 160: 35-46.
  5. Diagnosis and management of heparin-induced thrombocytopenia, 2nd edition. H Watson, S Davidson, D Keeling. Br J Haematol. 2012, 159: 528-540.
  6. Investigation and management of venous thrombosis at unusual sites. C Tait, T Baglin, H Watson et al. Br J Haematol. 2012, 159: 28-38.
  7. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo controlled trial. SOX Trial Investigators. Kahn SR, Shapiro S, Wells PS et al. Lancet 2014, 9920 383, 880-888.
  8. Superficial vein thrombosis: a current approach to management. Scott G, Mahdi A J, Alikhan R. Br J Haematol. 2015, 373: 697-704
  9. Carrier et al. Screening for occult cancer in unprovoked venous thromboembolism, SOME Investigators. NEJM. 2015, 373: 697-704.
  10. HAT Committee, UK Clinical Pharmacy Association for NHS healthcare professionals, June 2015.
  11. Baumgartner H, Falk V, Bax JJ et al 2017 ESC/EACTS Guidelines for the management of valvular heart disease. The task force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 2017:38; 2739-2791